Related Experiment Video
Updated: Nov 4, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Response to first dose of inhaled albuterol in mechanically ventilated preterm infants
Thomas M Raffay1, Mandy Brasher2, Brooke C Place3
1Pediatrics/Neonatology, UH Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH, USA.
Insights
Albuterol improved breathing in preterm infants by reducing airway resistance in 68% of cases. Hypoxemia also decreased, indicating a potential bedside measure for albuterol response in neonates.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Respiratory Physiology
Background:
- Bronchodilator responses in preterm infants are highly variable.
- Identifying infants who benefit from bronchodilators is crucial for effective respiratory support.
- Bedside measurements may offer a practical way to assess bronchodilator effectiveness.
Purpose of the Study:
- To evaluate the impact of albuterol on respiratory mechanics and oxygenation in preterm infants.
- To determine if bedside measurements can identify responders to albuterol.
- To assess the consistency of albuterol response with repeated doses.
Main Methods:
- Retrospective analysis of respiratory data (Resistance, Compliance, FiO2) and SpO2 in infants <30 weeks gestational age.
- Included 33 mechanically ventilated infants receiving their first dose of albuterol.
- Compared measurements before and after albuterol administration, with secondary analysis of subsequent doses.
Main Results:
- Mean airway resistance significantly decreased post-albuterol (p=0.007), with 68% of infants classified as responders.
- No significant changes were observed in compliance or FiO2.
- Percent time in hypoxemia (SpO2 <85%) decreased significantly post-albuterol (p<0.02).
- In responders, the magnitude of resistance change decreased with subsequent albuterol doses (p=0.01).
Conclusions:
- Albuterol effectively reduced airway resistance in a majority of preterm infants, aligning with findings from formal pulmonary function testing.
- While albuterol's effect on FiO2 was variable, decreased hypoxemia suggests its utility in assessing bronchodilator response.
- Bedside monitoring of hypoxemia may serve as a valuable tool for evaluating albuterol effectiveness in this population.
Background:
Bronchodilator responses among preterm infants are heterogeneous. Bedside measurements may identify responders.
Study Design:
Respiratory measurements (Resistance, Compliance, FiO2) and pulse oximetry (SpO2) patterns were downloaded from infants <30 weeks gestational age during the first 2 months of life. Mechanically ventilated infants who received albuterol were included (n = 33). Measurements were compared before and after first albuterol. Secondary analyses assessed subsequent doses.
Results:
Median gestation and birthweight were 25 3/7 weeks and 730 g, respectively. Mean Resistance decreased post-albuterol (p = 0.007). Sixty-eight percent of infants were responders based on decreased Resistance. Compliance and FiO2 did not significantly differ. Percent time in hypoxemia (SpO2 < 85%) decreased post albuterol (p < 0.02). In responders, Resistance changes diminished with subsequent administration (all p = 0.01).
Conclusions:
Ventilator resistance decreased in two-thirds of preterm infants, consistent with studies that utilized formal pulmonary function testing. Albuterol had a variable effect on delivered FiO2; however, hypoxemia may be useful in evaluating albuterol response.
More Related Videos
Related Concept Videos
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Mechanical Ventilation I: Indication and Settings
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Drug Dosing: Infants and Children
Pulmonary Cycle: Exhalation

